Birchview Capital, LP Neuro Pace Inc Transaction History
Birchview Capital, LP
- $111 Million
- Q1 2025
A detailed history of Birchview Capital, LP transactions in Neuro Pace Inc stock. As of the latest transaction made, Birchview Capital, LP holds 16,442 shares of NPCE stock, worth $147,649. This represents 0.18% of its overall portfolio holdings.
Number of Shares
16,442
Previous 10,000
64.42%
Holding current value
$147,649
Previous $111,000
81.98%
% of portfolio
0.18%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding NPCE
# of Institutions
99Shares Held
25.1MCall Options Held
1.8KPut Options Held
300-
Orbimed Advisors LLC San Diego, CA3.41MShares$30.6 Million1.3% of portfolio
-
Polar Capital Holdings PLC London, X02.97MShares$26.7 Million0.24% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.61MShares$23.4 Million2.65% of portfolio
-
Morgan Stanley New York, NY2.53MShares$22.7 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.58MShares$14.2 Million2.5% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $223M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...